WHAT IS NANOCELLE®?
NanoCelle® is a unique, patented delivery system with diverse applications.
QUICK FACTS
Improves compound solubility
Improves absorption
Reduces compound side effects
By-passes 1st pass metabolism
Improves Patient compliance
Improved onset
Significant in vitro and in vivo data
ROUTES OF ADMINISTRATION INCLUDE:
Oro-buccal (preferred - bypass 1st pass metabolism)
Topical
Ingestive
Nasal
Ocular
RESEARCH HAS SHOWN:
Extensive studies have been conducted, and results differ with different compounds, but over 400,000 NanoCelle® products have been dosed to patients with minimal side effects.
In vitro characterization done in collaboration with the University of Sydney
PK studies showed up too 5 times more compound is absorbed when compared to tablets, capsules, emulsions, and liposomes
Bioequivalence studies showed comparable levels to tablets 10x its dose.
Phase 1/2 studies showed safety, tolerability, and efficacy.
RWE Studies showed safety, tolerability, and efficacy over extended periods of time
The research portfolio showed no reported incident of CARPA.
STRUCTURE
NanoCelle® contains a nanoscopic fat-soluble core surrounded by a water-soluble outer layer. This structure enables the NanoCelle® solution to maintain high concentrations of selected nutrients, whilst delivering nano-particle-sized molecules of the compound (pharmaceutical/nutraceutical) for absorption across the oro-buccal mucosa.
Historical copy of ARTG-approved advertising based on published research.